HQ Function

The headquarters serves as the primary center for Solid Biosciences' research and development activities, clinical operations, manufacturing oversight, and corporate administration.

Notable Features:

The facility is likely equipped with state-of-the-art laboratory spaces tailored for gene therapy research, process development, and analytical testing. Its location in a biotech-focused development offers modern amenities and infrastructure.

Work Culture:

The work culture at Solid Biosciences is likely mission-driven, collaborative, and scientifically rigorous, with a strong emphasis on innovation and patient impact. Employees are typically passionate about addressing the challenges of Duchenne muscular dystrophy.

HQ Significance:

Being located in the Boston-Cambridge biotech cluster provides Solid Biosciences with access to a rich talent pool, leading academic and medical institutions, specialized service providers, and a vibrant community of potential collaborators, which is crucial for advancing their therapeutic programs.

Values Reflected in HQ: The headquarters' design and operation likely reflect Solid Biosciences' core values, such as scientific excellence, urgency in addressing patient needs, integrity, and collaboration, fostering an environment conducive to cutting-edge research.

Location:

Solid Biosciences's core operations, including research, development, and corporate functions, are primarily based in the United States. While their therapeutic candidates aim for eventual global availability to Duchenne patients, their physical office presence is currently concentrated at their Charlestown, MA headquarters. The company may engage in multinational clinical trials, involving sites and investigators in various countries as their programs progress.

Street Address:

500 Rutherford Avenue, Suite A

City:

Charlestown

State/Province:

MA

Country:

USA